Glucose-6- phosphate dehydrogenase deficiency
remains a global
as well as a North American
burden
for extreme hyperbilirubinemia and kernicterus and
is often unpredictable during the first few days after birth.
Newborn screening for this enzyme deficiency
is not universally available but debated.